Syntaxin 6: A potential biomarker for papillary renal cell carcinoma
A recent study published in Scientific Reports last month has [...]
Potential urine biomarkers for small renal masses
A recent study, published in the International Journal of Urology, [...]
ASCO GU 2019: Savolitinib and durvalumab in metastatic papillary kidney cancer
Results from this trial for papillary renal cell carcinoma (RCC) [...]
ASCO GU 2019: First-line pembrolizumab shows promise in non-clear cell RCC
The results from the following study were presented at the [...]
Immune signature for papillary RCC predicts outcomes
A recent study published in Cancer Medicine has identified immune-related [...]
Kidney stones associated with an increased risk of kidney cancer
A recent study involving 5,000 patients from The Netherlands who [...]
ESMO 2018: Axitinib for the treatment of metastatic papillary renal cell carcinoma in the first-line
The results from a phase 2 clinical trial to assess [...]
Obesity linked to the development of certain kidney cancer subtypes
Recent research has suggested that obesity is associated with the [...]
Immunotherapy for non-clear cell kidney cancer
The following interview with Dr Eric Jonasch, medical oncologist from [...]
An overview of the management of rare subtypes of kidney cancer
This interview with Dr Ramaprasad Srinivasan from the National Cancer Institute in [...]
